MedicineMolecular BiologyOncologyCarcinogenesisEpigeneticsGene ExpressionCancer MetabolismCancer TranscriptomicsMetabolic ReprogrammingMetabolic Reprogramming In CancerMetabolic SignalingG1 Phase ArrestHepatocellular Carcinoma PathogenesisM Phase ArrestN6-methyladenosine RegulationTumor Metabolism
N6-methyladenosine (m6A) acts as the most common mRNA modification in mammal cells. Fat Mass and Obesity-associated protein (FTO) is the firstly identified demethylase in the m6A modification. This research tries to discover the potential roles of FTO in the m6A modification in the hepatocellular carcinoma (HCC). FTO level was found to be up-regulated in the HCC tissue and cells. The over-expression of FTO was correlated to the poor prognosis of HCC individuals. Knockdown of FTO suppressed the proliferation and in vivo tumor growth, and induced the G0/G1 phase arrest. Mechanically, FTO triggered the demethylation of PKM2 mRNA and accelerated the translated production. Overall, this finding suggests the critical function of FTO in the HCC oncogenesis and its m6A modification.
18
Differential m6A, m6Am, and m1A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm
Jiangbo Wei, Fange Liu, Zhike Lu et al. · Molecular Cell · 2018 · 779 citations · Full text
Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally
Huilin Huang, Hengyou Weng, Keren Zhou et al. · Nature · 2019 · 703 citations
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
Yi Niu, Ziyou Lin, Arabella Wan et al. · Molecular Cancer · 2019 · 627 citations · Full text